World

Home / World / Americas

US NIH halts trial testing COVID-19 blood plasma

Updated: 2021-03-03 03:54

Share - WeChat

Empty beds are seen at a New York Blood Center in the Upper East Side neighborhood of Manhattan on December 02, 2020 in New York City. [Photo/Agencies]

March 2 - The US National Institutes of Health (NIH) said on Tuesday it had halted a trial testing convalescent blood plasma in treatment of patients with mild to moderate COVID-19 symptoms.

The NIH said an independent data monitoring board found that the plasma was unlikely to benefit this group of patients.

Reuters

Photos

US should face the facts on fentanyl issue, China says

South Korea's top court upholds Samsung boss's fraud acquittal

US to impose uniform tariff rate on over 150 economies: Trump

Brazil expresses 'indignation' over US tariffs

Study: Healthcare efficiency in China offers lessons to world

New center boosts table tennis development

Most Viewed in 24 Hours

World in Focus

Stopgap homes

Across Asia +

Competition intensifies as ASEAN nations vie for foreign visitors

Developing countries step up as global donors as landscape changes

Special Coverage +

Grow with SCO

Live: Middle East truce stands amid claims of victory

Friends Afar +

Comedy to the power of two equals understanding

Ties That Bind +

Vital pass to boost China-Pakistan trade

BACK TO THE TOP

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349